The nurse is administering a prescribed medication to neonatal client. Which factor is most likely to increase the risk for drug toxicity in this client?

A) Lying flat on the back: Positioning the client flat on their back is not the most effective position for administering a rectal suppository. The correct position allows for easier insertion and proper absorption of the medication. Lying flat on the back may make it difficult for the nurse to administer the suppository in the correct manner.

B) Lying flat on the stomach: Lying flat on the stomach is not recommended for the administration of a rectal suppository, as it can be uncomfortable for the client and can impede the ability to access the rectal area. The side-lying position is more effective for both client comfort and proper placement of the suppository.

C) Left side-lying: The left side-lying position, often referred to as the Sims' position, is the most appropriate for administering a rectal suppository. This position helps to expose the rectal area, allows for easier insertion, and promotes the suppository’s absorption, as gravity can assist in its positioning within the rectum.

D) Right side-lying: The right side-lying position is not as effective as the left side-lying position for the administration of a rectal suppository. The left-side position helps to ensure the smooth placement of the suppository and promotes its absorption. Therefore, the right side is not the optimal choice.

A) Omeprazole and clarithromycin: Omeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, and clarithromycin is an antibiotic used to target Helicobacter pylori (H. pylori), the bacteria responsible for many peptic ulcers. In dual therapy for H. pylori eradication, omeprazole is used to create a less acidic environment, enhancing the effectiveness of antibiotics like clarithromycin. This combination is one of the most commonly used regimens in the treatment of peptic ulcer disease caused by H. pylori.

B) Ciprofloxacin and sucralfate: Ciprofloxacin is an antibiotic, and sucralfate is a medication used to coat the stomach lining to protect it from acid. While ciprofloxacin may be effective against certain bacterial infections, it is not typically used in dual therapy for H. pylori infections. Sucralfate is not an antibiotic and does not directly treat the bacterial cause of peptic ulcers, so this combination would not be ideal for H. pylori eradication.

C) Cimetidine and amoxicillin: Cimetidine is an H2-receptor antagonist used to reduce stomach acid production, and amoxicillin is an antibiotic that could potentially target H. pylori. However, this combination is less commonly used compared to PPI-based therapies. Cimetidine does not reduce acid as effectively as omeprazole (a PPI), making this combination less ideal for eradicating H. pylori.

D) Tetracycline and metronidazole: Both tetracycline and metronidazole are antibiotics used to treat infections, including H. pylori, but they are typically used in triple therapy regimens along with a PPI, not in dual therapy. While they can be effective in treating H. pylori, the combination of a PPI like omeprazole with clarithromycin remains the preferred choice for dual therapy.